Kombiglyze XR
Type 2 Diabetes Mellitus
5/500 · 5/1000mg
Kombiglyze XR pairs saxagliptin with metformin in a prolonged-release tablet for type 2 diabetes mellitus, a DPP-4 inhibitor alongside a biguanide.
From$4.84/ tabletView
Saxagliptin
Saxagliptin functions as a DPP-4 inhibitor to manage blood glucose levels in adults, typically alongside diet and exercise. Kombiglyze XR is available, featuring the active ingredient saxagliptin in a prolonged-release format. This medication belongs to a class central to effective Diabetes Management.
Key points
- Is intended for type 2 diabetes management only, not for type 1 diabetes or diabetic ketoacidosis.
- Raises insulin output when blood sugar is high while also reducing the amount of sugar the liver releases.
- Comes as a prolonged-release tablet designed to release the medicine gradually, reducing how often it needs to be taken.
- Before starting, check that no other DPP-4 inhibitor medicine is already part of the treatment, to avoid duplication.
What is Saxagliptin?
Saxagliptin is a medication classified as a DPP-4 inhibitor, which regulates glucose levels by increasing natural hormones in your body. It is formulated to complement your existing dietary and exercise routines. Because medication responses vary, you may find that specific releases provide more consistency for your personal daily routine.
What Saxagliptin is used for
This compound is used primarily for the long-term management of Type 2 Diabetes. By working to keep post-meal blood sugar levels within a target range, the medication supports your body in processing glucose more effectively. It is not intended for the treatment of type 1 diabetes or diabetic ketoacidosis.
How does Saxagliptin work?
This ingredient works by blocking the enzyme that breaks down incretin hormones. These hormones increase the amount of insulin produced when your blood sugar is high and lower the amount of sugar produced by your liver. This combined process maintains balanced glucose levels throughout the day.
Saxagliptin brands and forms
The primary formulation listed is the prolonged-release tablet of Kombiglyze. Prolonged-release technology is designed to distribute the active ingredient gradually over a longer period, which can simplify your daily routine by reducing the number of times you need to take the medication. When choosing a product, consider the release mechanism and your preference for how you take the tablet.
Safety overview for Saxagliptin
What to check before using this medicine
Verify that this medication aligns with your current health profile, including your kidney and liver status. You should confirm the active ingredients to avoid sensitivities or duplication of similar DPP-4 inhibitor treatments.
Possible reactions and tolerability
Common responses can include mild respiratory symptoms, urinary tract issues, or digestive discomfort. Monitor your glucose levels regularly to observe how your body reacts to the introduction of this medication.
Interactions and health factors
Certain medications, especially those affecting glucose metabolism or insulin secretion, may interact with this compound. Product labelling and verified clinical sources remain the correct references for specific contraindications, interactions and reactions.